Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 7.7% decrease from the number of companies inspected in the previous quarter, when 13 companies received 13 inspections.
Most of the companies inspected at the time were involved in the Biologics sector. Both the Food and Cosmetics and Devices sectors sectors tied for second most common type.
There were nine companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions (75%). Two should take voluntary action to correct the organization's management operations (16.7%). Additionally, one company had to take regulatory and/or administrative actions (8.3%).
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Central States Foods, Inc. | Food and Cosmetics | 05/25/2023 | Voluntary Action Indicated (VAI) |
Edge Biologicals, Inc. | Devices | 04/04/2023 | Official Action Indicated (OAI) |
Hemostatix Medical Technologies, LLC | Devices | 05/02/2023 | No Action Indicated (NAI) |
Le Bonheur Children's Medical Center | Biologics | 04/27/2023 | No Action Indicated (NAI) |
M. Palazola Produce Company | Food and Cosmetics | 04/04/2023 | No Action Indicated (NAI) |
Natureplex, LLC | Food and Cosmetics | 06/06/2023 | No Action Indicated (NAI) |
Odyssey Medical Technologies, LLC. | Devices | 04/03/2023 | Voluntary Action Indicated (VAI) |
SpinalGraft Technologies, LLC | Biologics | 06/14/2023 | No Action Indicated (NAI) |
The Kellogg Company | Food and Cosmetics | 06/08/2023 | No Action Indicated (NAI) |
University of Tennessee Health Science Center IRB | Biologics | 06/30/2023 | No Action Indicated (NAI) |
University of Tennessee Health Science Center IRB | Devices | 06/30/2023 | No Action Indicated (NAI) |
University of Tennessee Health Science Center IRB | Drugs | 06/30/2023 | No Action Indicated (NAI) |
Veterans Affairs Medical Center | Biologics | 04/11/2023 | No Action Indicated (NAI) |
Vitalant | Biologics | 05/11/2023 | No Action Indicated (NAI) |